Compare Bundamedik Tbk (BMHS) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bundamedik Tbk trades at Rp188 (market cap 1.63T, 725.9K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Bundamedik Tbk is far larger — about 5.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Bundamedik Tbk is more actively traded (725.9K versus 41.7K). Which is the better fit depends on your goals.
| BMHS | DGNS | |
|---|---|---|
Market Cap | 1.63T | 316.25B |
Volume | 725.9K | 41.7K |
Lot | 7.26K | 417 |
Turnover | 135.94M | 9.66M |
Average Price | 187.26 | 231.65 |
Value | 135.94M | 9.66M |
Indicative Equilibrium Price | 188 | 230 |
Indicative Equilibrium Volume | 1 | 2.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
